If you need more lookups,
subscriptions start at $34 USD/month.
Fabio Cataldi Location
Boston, MA, US
Fabio Cataldi Work
EVP and Chief Medical Officer @ (August 2024 - Present)
VP and Therapeutic Area Head Gastroenterology @ Arena Pharmaceuticals, Inc./Pfizer (June 2019 - August 2022)
Team Lead Gastroenterology and Immunology Global Pharmaceutical Research and Development @ (August 2017 - June 2019)
Vice President Global Clinical Development @ (July 2015 - July 2017)
Senior Director Gastroenterology Biotherapeutics Clinical Programs Research and Development @ (January 2010 - July 2015)
Director, Medical Research Immunology-Gastroenterology @ (September 2007 - October 2010)
Medical Director, Uscdma-Clinical Development and Medical Affairs Gastroenterology @ (September 2004 - September 2007)
Assistant Director, Clinical Operations and Medical Affairs Gastroenterology @ Solvay Pharmaceuticals (September 2002 - September 2004)
Research Fellow Gastroenterology @ (January 1998 - January 2002)
Fabio Cataldi Education
Second University of Naples
Doctor of Medicine (Medicine)
1985-1997
Fabio Cataldi Skills
Inflammatory Bowel Disease
Clinical Development
Pharmaceutical Industry
Clinical Trials
Drug Development
Clinical Research
Medical Affairs
Gastroenterology
R&D
Medical Research
Cancer
Immunology
GCP
Medicine
Oncology
Biotechnology
CTMS
Medical Writing
Regulatory Affairs
CRO
Drug Discovery
Therapeutic Areas
Fabio Cataldi Summary
Fabio Cataldi, based in Boston, MA, US, is currently a EVP and Chief Medical Officer at Abivax. Fabio Cataldi brings experience from previous roles at Arena Pharmaceuticals, Inc./Pfizer, AbbVie, Shire and Pfizer. Fabio Cataldi holds a 1985 - 1997 Doctor of Medicine in Medicine @ Second University of Naples. With a robust skill set that includes Inflammatory Bowel Disease, Clinical Development, Pharmaceutical Industry, Clinical Trials, Drug Development and more. Fabio Cataldi has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Fabio Cataldi?
Find contact details for 700 million professionals.